REMEDIES

Home » News » ReMediES partners Juniper and Crystec sign agreement for next generation medicines

ReMediES partners Juniper and Crystec sign agreement for next generation medicines

Crystec and Juniper Pharma Services are working together as part of the Advanced Manufacturing Supply Chain Initiative (AMSCI) project, ReMediES. Juniper Pharma Services will bring its expertise in characterisation, formulation development and GMP production to the supercritical fluid (SCF) manufacturing platform, ultimately reshoring this high value manufacturing process to the United Kingdom.

Read the full press release here: http://www.juniperpharma.com/juniper-and-crystec-sign-agreement-for-next-generation-medicines/.